// June 26, 2023
Complex generics: Are global regulators addressing the needs?
The development of generic versions of innovator medicines is a global public health need.
The development of generic versions of innovator medicines is a global public health need.
In the U.S. and around the world, quality standards developed by the U.S.
In 2019, the World Health Organization (WHO) declared antimicrobial resistance (AMR) one of the t
Antimicrobial resistance (AMR) occurs when microbes, such as bacteria, viruses and parasites, cha